GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 93 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2016. The put-call ratio across all filers is 1.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $29,500,000 | -12.7% | 535,000 | 0.0% | 0.58% | -21.4% |
| Q2 2020 | $33,775,000 | +23.6% | 535,000 | 0.0% | 0.73% | -17.1% |
| Q1 2020 | $27,333,000 | -35.7% | 535,000 | 0.0% | 0.88% | -26.1% |
| Q4 2019 | $42,527,000 | +63.8% | 535,000 | 0.0% | 1.20% | +39.6% |
| Q3 2019 | $25,958,000 | -7.8% | 535,000 | 0.0% | 0.86% | +0.4% |
| Q2 2019 | $28,141,000 | +44.9% | 535,000 | +45.8% | 0.86% | +28.0% |
| Q1 2019 | $19,425,000 | +28.9% | 367,000 | 0.0% | 0.67% | +0.1% |
| Q4 2018 | $15,065,000 | +72.4% | 367,000 | +59.6% | 0.67% | +107.8% |
| Q3 2018 | $8,740,000 | +48.1% | 230,000 | +21.1% | 0.32% | -3.9% |
| Q3 2017 | $5,900,000 | +13.5% | 190,000 | 0.0% | 0.33% | +3.1% |
| Q2 2017 | $5,197,000 | -14.5% | 190,000 | +15.2% | 0.32% | -19.6% |
| Q1 2017 | $6,080,000 | +155.0% | 165,000 | 0.0% | 0.40% | +160.0% |
| Q4 2016 | $2,384,000 | -37.3% | 165,000 | 0.0% | 0.16% | -33.2% |
| Q3 2016 | $3,803,000 | +38.9% | 165,000 | 0.0% | 0.23% | +38.9% |
| Q2 2016 | $2,737,000 | +4.6% | 165,000 | 0.0% | 0.17% | +14.4% |
| Q1 2016 | $2,617,000 | -50.9% | 165,000 | 0.0% | 0.15% | -45.3% |
| Q4 2015 | $5,334,000 | +716.8% | 165,000 | +966.0% | 0.27% | +602.6% |
| Q3 2015 | $653,000 | – | 15,479 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |